Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Binsheng Zhao
Columbia University Health Sciences, Department: Radiation Diagnostic/oncology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Keosys
Other : Royalties received through the institution
Dr. Zhao is entitled to receive an inventor’s share of license fees and royalties through separate licenses from Columbia University to Keosys and Varian. (Columbia’s Policy on Financial Conflicts of Interest and Research includes royalties above $5,000, even if received through the University, in the definition of “significant financial interest.”) Dr. Zhao received her first payments (approximately (b)(4) from each company) in December 2013. Dr. Zhao continues to conduct research that relates to segmentation algorithms covered by these licenses. In light of these facts, Columbia has determined that the outcome of this research could affect the value of the license and Dr. Zhao’s financial interest, and that the design, conduct, and/or reporting of this research could be affected by this financial interest.
Studying measurement variability in tumor volume and volume change on MDCT
Confirmation of the ability of VCT to detect earlier response or progression would lower the cost and accelerate the timelines of future clinical trials. The outcome of this study will be of great value in helping establish standards of imaging protocols and response criteria for the use of VCT in clinical trials and clinical care where treatment benefit is measured by the changes in tumor size assessed by CT.
Filed on August 05, 2014.
Tell us what you know about Binsheng Zhao's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Binsheng Zhao filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Binsheng Zhao | Columbia University Health Sciences | Conflict of Interest | Varian Medical Systems | $20,000 - $39,999 |
| Binsheng Zhao | Columbia University Health Sciences | Conflict of Interest | Varian | $10,000 - $19,999 |
| Binsheng Zhao | Columbia University Health Sciences | Conflict of Interest | Keosys | $10,000 - $19,999 |
| Binsheng Zhao | Columbia University Health Sciences | Conflict of Interest | Varian | $10,000 - $19,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.